DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Free cash flow, 2025
- $1.4B
- YoY, 2025
- +49.5%
- 5-year CAGR
- −3.1%
- 10-year CAGR
- +9.3%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $1.4B | +49.5% |
| 2024 | $909M | +5.2% |
| 2023 | $864M | −34.2% |
| 2022 | $1.3B | −28.2% |
| 2021 | $1.8B | +15.3% |
| 2020 | $1.6B | +88.3% |
| 2019 | $843M | +3.2% |
| 2018 | $817M | −11.5% |
| 2017 | $923M | +12.2% |
| 2016 | $823M | +47.5% |
| 2015 | $558M | −12.3% |
| 2014 | $636M | +51.1% |
| 2013 | $421M | −58.1% |
| 2012 | $1.0B | +36.9% |
| 2011 | $734M | −19.6% |
| 2010 | $913M | +9.9% |
| 2009 | $830M | −2.3% |
| 2008 | $850M | +20.1% |
| 2007 | $708M | — |